Skip to Main Content

Paper Details

Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature.
J Immunother Cancer
12
2022
20-gene signature, CINSARC, ICR, ICR), ICR1, ICR2, ICR3, ICR4, STS, STSs, Sarcomas, Soft-tissue sarcomas, immunologic constant of rejection (, patients, soft-tissue sarcoma, tumor, tumors
Author NameAffiliation
Michele CeccarelliUniversity of Naples Federico II Faculty of Engineering
Davide Bedognetti
Davide BedognettiUniversity of Genova
Daniel BirnbaumInstitut Paoli-Calmettes, Aix-Marseille Universite, INSERM UMR8, CNRS UMR725
  • 1 - 4

Datasets

Release 1.2